PharmaBoardroom

Gene-modified Babies in China Highlight Regulatory Concerns of…

Aditya Bhattacharji manages Eurasia Group‘s healthcare analysis and Kevin Allison is the director of geo-technology. Together they look at last…

Sunyoung Kim – Founder and CEO, ViroMed, South Korea

Sunyoung Kim, CEO and founder of ViroMed, reveals his strategy for conquering the US market and the feasibility of his ambitions for ViroMed to become…

Tuğçe Koç – Board Member, Onko Koçsel, Turkey

Tuğçe Koç reveals how Onko Koçsel was able to quickly grow from an in-licenser to a production-oriented pharmaceutical company with an…

David Ho – Managing Director, Hovid, Malaysia

David Ho, managing director of Hovid, introduces the success story of his family-owned company, which started at a Chinese herbal tea manufacturer and…

Abidin Gulmus – Founder and Chairman, Gen Ilaç, Turkey

Abidin Gulmus, founder and chairman of Gen Ilaç, describes the company’s impressive journey to become Turkey’s principle orphan drug distributor…

Jongmoon Kim – CEO, ToolGen, South Korea

Jongmoon Kim, CEO of ToolGen discusses the potential for their CRISPR technology to revolutionize not only therapy for genetic illnesses, but also…

Jean Monin – General Manager, Amgen France

Jean Monin, general manager of Amgen France, discusses the challenges of bringing products to market in France and what is needed to better promote…

Tahsin Yüksel – General Manager, Teva Turkey

Tahsin Yüksel, general manager of Teva Turkey, analyzes the strategic importance of pharmaceutical branding in Turkey, shares the story of Teva’s…

Fabio Sperandei – Country Head, Sandoz Malaysia

Fabio Sperandei has been the country head for Sandoz Malaysia for four years. Here, he explains the key success factors that led Sandoz to become the…

Catherine Bourrienne-Bautista – Delegate General, GEMME,…

Catherine Bourrienne-Bautista, Déléguée générale of the GEMME (L’association Genérique Même Medicament, France’s generics and biosimilars…

Ch’ng Kien Peng – Executive Director, Xepa-Soul…

Ch’ng Kien Peng, executive director of Xepa-Soul Pattinson, offers insights on the dynamic healthcare industry in Malaysia and the new…

Indranil Sen – Managing Director, Ranbaxy (A Sun Pharma…

Indranil Sen, managing director of Ranbaxy Malaysia, a Sun Pharma company, discusses the role of generics in the Malaysian pharmaceutical sector, and…

Tagged with GEN